MORGAN STANLEY: Here are the 10 healthcare companies most likely to get bought this year
AP
Allergan is among the healthcare companies Morgan Stanley sees as a possible M&A target.
It's shaping up to be a big year for healthcare M&A.
In the month of January alone, there was a total of $27.5 billion worth of deals, including a $9 billion deal for a cancer drugmaker and a bidding war for a Belgian biotech.While it's easy to determine who might be in the mood to do some acquiring, spotting the targets can be a bit more difficult.
To help out, Morgan Stanley compiled a list of large and liquid companies it thinks will get at least one tender offer over the next 12 months. While the Morgan Stanley note contained 21 companies, we stuck to just the top 10 by market cap and trading volume.Mylan
Ticker: MYL
Company summary: Mylan, known for its generic drug business and as the maker of the EpiPen, got a boost in October 2017 when the FDA approved its generic version of the multiple sclerosis drug Copaxone.
Market cap: $22.7 billion
Iqvia Holdings
Ticker: IQV
Company summary: Iqvia, formerly known as Quintiles IMS Holdings, does both clinical trials for pharmaceutical companies and analyzes industry data. It's one of the largest contract research organizations, companies that have been going through a lot of M&A.
Market cap: $23.1 billion
Edwards Lifesciences
Ticker: EW
Company summary: Edwards Lifesciences is a medical device company that makes heart valves and other devices used in surgical procedures.
Market cap: $23.8 billion
Zimmer Biomet
Ticker: ZBH
Company summary: Zimmer Biomet is a medical device company that makes products used in knee and hip replacements and other surgical procedures.
Market cap: $24.4 billion
Alexion Pharmaceuticals
Ticker: ALXN
Company summary: Alexion, a rare disease drugmaker, has been under pressure from activist investors to get its stock up, and both its CEO and CFO left the company in 2017.
Market cap: $26.6 billion
HCA Healthcare
Ticker: HCA
Company summary: HCA, an acronym for Hospital Corporation of America, operates 177 hospitals and 119 surgery centers in the US and the UK and other facility-based companies.
Market cap: $31.3 billion
Illumina
Ticker: ILMN
Company summary: Gene-sequencing company Illumina makes technology that has drastically brought down the cost of reading all the information in your genome.
Market cap: $31.9 billion
Boston Scientific
Ticker: BSX
Company summary: Boston Scientific is a medical device company known for its pacemakers and medical equipment.
Market cap: $34 billion
Express Scripts
Ticker: ESRX
Company summary: Express Scripts is pharmacy benefits manager, or a company that negotiates discounts to drug prices for health plans in the form of rebates. Express Scripts is the largest standalone PBM, and its stock has been weathering news that Amazon is interested in getting into healthcare.
Market cap: $42.2 billion
Allergan
Ticker: AGN
Company summary: Allergan, the drugmaker behind Botox, had an interesting 2017. The company struck an unusual deal with the Saint Regis Mohawk Tribe to transfer patents of the eye drug Restasis. The move drew a lot of backlash.
Market cap: $54.4 billion
Next Story
Here’s how Indians are buying Tesla, Facebook, and Apple shares through brokerage startups
-
Radio ad revenue for July-Sept quarter in 2020 was Rs 198.53 crore: TRAI
-
YouTube starts rolling out hashtag landing pages— here’s how you can use it
-
Do not panic when Finance Minister Nirmala Sitharaman reads out the revised estimates
-
India records 14,545 new COVID-19 cases in last 24 hours
Next